October 27, 2021
Inceptor Bio Announces Agreement to Acquire Gainesville, FL GMP Facility And Transfer Operating Team From Arranta Bio To Accelerate Cell Therapies To Cure Cancer
Read More
July 22, 2021
The Past, Present, and Future of Gene Editing
Watch
July 7, 2021
Inceptor Bio Launches FastBack Bio, Its First Portfolio Company Developing A Novel CAR-T Platform That Targets Difficult-To-Treat Cancers
Read More
June 23, 2021
Beyond CAR-T: Other Engineered Immune Cells
Watch
June 14, 2021
Inceptor Bio Launches Next-Generation CAR-T, CAR-M, and NK/NKT Platform Focused on Advancing Cell and Gene Therapies to Cure Difficult-To-Treat Cancers
Read More
October 19-21, 2021
2021 BIO Investor Forum Digital
Book a Meeting
January 10-13, 2022
JP Morgan 40th Annual Healthcare Conference
Book a Meeting
December 10, 2020
How Does Inceptor Bio Envision the Future of the Pharma/Biopharma Industry?
Read More